{"product_id":"matrixyl-10mg-vial","title":"Matrixyl 10mg vial","description":"\u003cp data-start=\"84\" data-end=\"346\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e                                           \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003eFOR HUMAN CONSUMPTION\u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"84\" data-end=\"346\"\u003e\u003cstrong data-start=\"84\" data-end=\"97\"\u003eMatrixyl®\u003c\/strong\u003e is a \u003cstrong data-start=\"103\" data-end=\"117\"\u003etrade name\u003c\/strong\u003e most commonly associated with the cosmetic peptide \u003cstrong data-start=\"169\" data-end=\"197\"\u003epalmitoyl pentapeptide-4\u003c\/strong\u003e (often written \u003cstrong data-start=\"213\" data-end=\"226\"\u003ePal-KTTKS\u003c\/strong\u003e), a \u003cstrong data-start=\"231\" data-end=\"260\"\u003epalmitoylated “matrikine”\u003c\/strong\u003e designed for topical anti-aging formulations. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"348\" data-end=\"651\"\u003e\u003cstrong data-start=\"348\" data-end=\"366\"\u003eMatrixyl 3000®\u003c\/strong\u003e is a \u003cstrong data-start=\"372\" data-end=\"389\"\u003epeptide blend\u003c\/strong\u003e best known for combining \u003cstrong data-start=\"415\" data-end=\"441\"\u003epalmitoyl tripeptide-1\u003c\/strong\u003e (historically “palmitoyl oligopeptide”) with \u003cstrong data-start=\"487\" data-end=\"515\"\u003epalmitoyl tetrapeptide-7\u003c\/strong\u003e (often described as an anti-inflammatory \/ anti-IL-6 signaling peptide in skincare literature). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"653\" data-end=\"860\"\u003e\u003cstrong data-start=\"653\" data-end=\"687\"\u003eRegulatory status (practical):\u003c\/strong\u003e Matrixyl peptides are \u003cstrong data-start=\"710\" data-end=\"734\"\u003ecosmetic ingredients\u003c\/strong\u003e (not FDA\/EMA “drug” actives) and are typically used in leave-on products aimed at improving the \u003cstrong data-start=\"831\" data-end=\"845\"\u003eappearance\u003c\/strong\u003e of aging skin.\u003c\/p\u003e\n\u003chr data-start=\"862\" data-end=\"865\"\u003e\n\u003ch2 data-start=\"867\" data-end=\"913\"\u003e2) Chemical and biological design rationale\u003c\/h2\u003e\n\u003ch3 data-start=\"915\" data-end=\"940\"\u003e2.1 Why “palmitoyl-”?\u003c\/h3\u003e\n\u003cp data-start=\"941\" data-end=\"1040\"\u003ePalmitoylation (attachment of a C16 fatty chain) is a common cosmetic-peptide strategy intended to:\u003c\/p\u003e\n\u003cul data-start=\"1041\" data-end=\"1280\"\u003e\n\u003cli data-start=\"1041\" data-end=\"1070\"\u003e\n\u003cp data-start=\"1043\" data-end=\"1070\"\u003eincrease \u003cstrong data-start=\"1052\" data-end=\"1069\"\u003elipophilicity\u003c\/strong\u003e,\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1071\" data-end=\"1127\"\u003e\n\u003cp data-start=\"1073\" data-end=\"1127\"\u003eimprove \u003cstrong data-start=\"1081\" data-end=\"1122\"\u003epartitioning into the stratum corneum\u003c\/strong\u003e, and\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1128\" data-end=\"1280\"\u003e\n\u003cp data-start=\"1130\" data-end=\"1280\"\u003eincrease \u003cstrong data-start=\"1139\" data-end=\"1157\"\u003eresidence time\u003c\/strong\u003e vs a non-lipidated peptide (which would be rapidly degraded and poorly permeable). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"1282\" data-end=\"1300\"\u003e2.2 Why KTTKS?\u003c\/h3\u003e\n\u003cp data-start=\"1301\" data-end=\"1532\"\u003eThe \u003cstrong data-start=\"1305\" data-end=\"1314\"\u003eKTTKS\u003c\/strong\u003e sequence is described as a \u003cstrong data-start=\"1342\" data-end=\"1392\"\u003ecollagen type I fragment (“matrikine” concept)\u003c\/strong\u003e—a signal-like peptide meant to “tell” fibroblasts that extracellular matrix (ECM) repair is needed. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"1534\" data-end=\"1537\"\u003e\n\u003ch2 data-start=\"1539\" data-end=\"1574\"\u003e3) Molecular mechanism of action\u003c\/h2\u003e\n\u003ch3 data-start=\"1576\" data-end=\"1645\"\u003e3.1 Palmitoyl pentapeptide-4 (Matrixyl): fibroblast ECM signaling\u003c\/h3\u003e\n\u003cp data-start=\"1646\" data-end=\"1773\"\u003eMechanistic reviews consistently describe \u003cstrong data-start=\"1688\" data-end=\"1701\"\u003ePal-KTTKS\u003c\/strong\u003e as upregulating dermal ECM components in fibroblast systems, including:\u003c\/p\u003e\n\u003cul data-start=\"1774\" data-end=\"1950\"\u003e\n\u003cli data-start=\"1774\" data-end=\"1813\"\u003e\n\u003cp data-start=\"1776\" data-end=\"1813\"\u003e\u003cstrong data-start=\"1776\" data-end=\"1812\"\u003eprocollagen \/ collagen synthesis\u003c\/strong\u003e,\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1814\" data-end=\"1848\"\u003e\n\u003cp data-start=\"1816\" data-end=\"1848\"\u003e\u003cstrong data-start=\"1816\" data-end=\"1843\"\u003eelastin and fibronectin\u003c\/strong\u003e, and\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1849\" data-end=\"1950\"\u003e\n\u003cp data-start=\"1851\" data-end=\"1950\"\u003e\u003cstrong data-start=\"1851\" data-end=\"1887\"\u003ehyaluronic-acid–related pathways\u003c\/strong\u003e (e.g., HAS1 in vitro). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"1952\" data-end=\"2006\"\u003e3.2 Matrixyl 3000: ECM support + inflammatory tone\u003c\/h3\u003e\n\u003cp data-start=\"2007\" data-end=\"2054\"\u003eMatrixyl 3000’s components are often framed as:\u003c\/p\u003e\n\u003cul data-start=\"2055\" data-end=\"2293\"\u003e\n\u003cli data-start=\"2055\" data-end=\"2113\"\u003e\n\u003cp data-start=\"2057\" data-end=\"2113\"\u003e\u003cstrong data-start=\"2057\" data-end=\"2083\"\u003epalmitoyl tripeptide-1\u003c\/strong\u003e → ECM “repair signaling,” and\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2114\" data-end=\"2293\"\u003e\n\u003cp data-start=\"2116\" data-end=\"2293\"\u003e\u003cstrong data-start=\"2116\" data-end=\"2144\"\u003epalmitoyl tetrapeptide-7\u003c\/strong\u003e → reduction of \u003cstrong data-start=\"2160\" data-end=\"2186\"\u003einflammatory signaling\u003c\/strong\u003e (commonly via \u003cstrong data-start=\"2201\" data-end=\"2220\"\u003eIL-6 modulation\u003c\/strong\u003e in cosmetic science narratives). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cblockquote data-start=\"2295\" data-end=\"2552\"\u003e\n\u003cp data-start=\"2297\" data-end=\"2552\"\u003eScientific caveat: Most mechanistic claims are based on \u003cstrong data-start=\"2353\" data-end=\"2365\"\u003ein vitro\u003c\/strong\u003e or supplier-compiled datasets; the most defensible clinical claim is improvement in \u003cstrong data-start=\"2450\" data-end=\"2472\"\u003eappearance metrics\u003c\/strong\u003e (wrinkle depth\/roughness\/elasticity), not “rebuilding” skin in a medical sense.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-start=\"2554\" data-end=\"2557\"\u003e\n\u003ch2 data-start=\"2559\" data-end=\"2624\"\u003e4) Pharmacokinetics and delivery constraints (topical reality)\u003c\/h2\u003e\n\u003cp data-start=\"2625\" data-end=\"2698\"\u003eMatrixyl peptides are used \u003cstrong data-start=\"2652\" data-end=\"2665\"\u003etopically\u003c\/strong\u003e, and their “PK” is really about:\u003c\/p\u003e\n\u003cul data-start=\"2699\" data-end=\"2992\"\u003e\n\u003cli data-start=\"2699\" data-end=\"2762\"\u003e\n\u003cp data-start=\"2701\" data-end=\"2762\"\u003e\u003cstrong data-start=\"2701\" data-end=\"2734\"\u003eskin penetration\/partitioning\u003c\/strong\u003e (helped by palmitoylation),\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2763\" data-end=\"2811\"\u003e\n\u003cp data-start=\"2765\" data-end=\"2811\"\u003e\u003cstrong data-start=\"2765\" data-end=\"2784\"\u003elocal stability\u003c\/strong\u003e in a cosmetic vehicle, and\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2812\" data-end=\"2992\"\u003e\n\u003cp data-start=\"2814\" data-end=\"2992\"\u003eachieving sufficient local concentration near viable epidermis\/upper dermis to influence fibroblast signaling indirectly or via diffusion. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"2994\" data-end=\"2997\"\u003e\n\u003ch2 data-start=\"2999\" data-end=\"3045\"\u003e5) Evidence base (clinical and preclinical)\u003c\/h2\u003e\n\u003ch3 data-start=\"3047\" data-end=\"3091\"\u003e5.1 Human studies (what exists publicly)\u003c\/h3\u003e\n\u003cul data-start=\"3092\" data-end=\"3833\"\u003e\n\u003cli data-start=\"3092\" data-end=\"3323\"\u003e\n\u003cp data-start=\"3094\" data-end=\"3323\"\u003eA 2023 randomized, split-face style clinical study investigated peptide-based topical approaches including \u003cstrong data-start=\"3201\" data-end=\"3229\"\u003epalmitoyl pentapeptide-4\u003c\/strong\u003e for crow’s feet outcomes (wrinkle-related endpoints). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3324\" data-end=\"3600\"\u003e\n\u003cp data-start=\"3326\" data-end=\"3600\"\u003eA 2020 clinical paper discussing \u003cstrong data-start=\"3359\" data-end=\"3387\"\u003epalmitoyl pentapeptide-4\u003c\/strong\u003e notes prior work (commonly attributed to Robinson et al.) reporting \u003cstrong data-start=\"3456\" data-end=\"3481\"\u003esmall but significant\u003c\/strong\u003e wrinkle\/fine-line improvements over ~12 weeks at commonly used concentrations. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3601\" data-end=\"3833\"\u003e\n\u003cp data-start=\"3603\" data-end=\"3833\"\u003eMany “Matrixyl 3000” performance statements are frequently repeated in cosmetic education sources; treat these as \u003cstrong data-start=\"3717\" data-end=\"3739\"\u003esupporting context\u003c\/strong\u003e unless tied to a peer-reviewed methods\/results paper. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"3835\" data-end=\"3901\"\u003e5.2 Preclinical \/ mechanistic evidence (stronger but indirect)\u003c\/h3\u003e\n\u003cp data-start=\"3902\" data-end=\"4314\"\u003eA 2025 review summarizes palmitoyl pentapeptide-4 as increasing \u003cstrong data-start=\"3966\" data-end=\"3981\"\u003eprocollagen\u003c\/strong\u003e and affecting \u003cstrong data-start=\"3996\" data-end=\"4025\"\u003ehyaluronic-acid synthesis\u003c\/strong\u003ein fibroblast systems, consistent with the ECM-support mechanism. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003cbr data-start=\"4131\" data-end=\"4134\"\u003eBroader peptide reviews also describe KTTKS-related fragments as supporting collagen, elastin, fibronectin, and glycosaminoglycan biology. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"4316\" data-end=\"4557\"\u003e\u003cstrong data-start=\"4316\" data-end=\"4342\"\u003eEvidence-quality note:\u003c\/strong\u003e Topical cosmetic peptides often show \u003cstrong data-start=\"4380\" data-end=\"4402\"\u003emodest-to-moderate\u003c\/strong\u003e improvements in appearance metrics, with outcomes depending heavily on \u003cstrong data-start=\"4474\" data-end=\"4489\"\u003eformulation\u003c\/strong\u003e, \u003cstrong data-start=\"4491\" data-end=\"4508\"\u003econcentration\u003c\/strong\u003e, \u003cstrong data-start=\"4510\" data-end=\"4526\"\u003estudy design\u003c\/strong\u003e, and \u003cstrong data-start=\"4532\" data-end=\"4556\"\u003ebaseline photodamage\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr data-start=\"4559\" data-end=\"4562\"\u003e\n\u003ch2 data-start=\"4564\" data-end=\"4630\"\u003e6) Practical “benefits” (appearance-focused, evidence-weighted)\u003c\/h2\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"4632\" data-end=\"5421\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"4632\" data-end=\"4686\"\u003e\n\u003ctr data-start=\"4632\" data-end=\"4686\"\u003e\n\u003cth data-start=\"4632\" data-end=\"4649\" data-col-size=\"md\"\u003eBenefit domain\u003c\/th\u003e\n\u003cth data-start=\"4649\" data-end=\"4677\" data-col-size=\"sm\"\u003eWhat’s realistic to claim\u003c\/th\u003e\n\u003cth data-start=\"4677\" data-end=\"4686\" data-col-size=\"md\"\u003eNotes\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"4701\" data-end=\"5421\"\u003e\n\u003ctr data-start=\"4701\" data-end=\"4890\"\u003e\n\u003ctd data-start=\"4701\" data-end=\"4735\" data-col-size=\"md\"\u003eFine lines \/ wrinkle appearance\u003c\/td\u003e\n\u003ctd data-start=\"4735\" data-end=\"4766\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4737\" data-end=\"4765\"\u003eImprovement is plausible\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4766\" data-end=\"4890\" data-col-size=\"md\"\u003eSupported by clinical and mechanistic literature, typically modest effect sizes. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4891\" data-end=\"5064\"\u003e\n\u003ctd data-start=\"4891\" data-end=\"4919\" data-col-size=\"md\"\u003eSkin texture \/ smoothness\u003c\/td\u003e\n\u003ctd data-start=\"4919\" data-end=\"4947\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4921\" data-end=\"4946\"\u003ePlausible improvement\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4947\" data-end=\"5064\" data-col-size=\"md\"\u003eOften tracks with hydration + ECM support and reduced roughness measures. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"5065\" data-end=\"5220\"\u003e\n\u003ctd data-start=\"5065\" data-end=\"5102\" data-col-size=\"md\"\u003eElasticity \/ firmness (appearance)\u003c\/td\u003e\n\u003ctd data-start=\"5102\" data-end=\"5117\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"5104\" data-end=\"5116\"\u003ePossible\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"5117\" data-end=\"5220\" data-col-size=\"md\"\u003eUsually secondary endpoints; depends on vehicle + duration. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"5221\" data-end=\"5421\"\u003e\n\u003ctd data-start=\"5221\" data-end=\"5277\" data-col-size=\"md\"\u003eSensitivity\/redness modulation (Matrixyl 3000 claims)\u003c\/td\u003e\n\u003ctd data-start=\"5277\" data-end=\"5305\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"5279\" data-end=\"5304\"\u003ePossible but variable\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"5305\" data-end=\"5421\" data-col-size=\"md\"\u003eOften attributed to palmitoyl tetrapeptide-7 and IL-6-linked narratives. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"5423\" data-end=\"5426\"\u003e\n\u003ch2 data-start=\"5428\" data-end=\"5457\"\u003e7) Safety and tolerability\u003c\/h2\u003e\n\u003cp data-start=\"5458\" data-end=\"5590\"\u003eFor most users, Matrixyl-type peptides are considered \u003cstrong data-start=\"5512\" data-end=\"5530\"\u003ewell tolerated\u003c\/strong\u003e in leave-on cosmetics, with adverse events primarily being:\u003c\/p\u003e\n\u003cul data-start=\"5591\" data-end=\"5824\"\u003e\n\u003cli data-start=\"5591\" data-end=\"5721\"\u003e\n\u003cp data-start=\"5593\" data-end=\"5721\"\u003emild \u003cstrong data-start=\"5598\" data-end=\"5612\"\u003eirritation\u003c\/strong\u003e, \u003cstrong data-start=\"5614\" data-end=\"5626\"\u003estinging\u003c\/strong\u003e, or \u003cstrong data-start=\"5631\" data-end=\"5653\"\u003econtact dermatitis\u003c\/strong\u003e (usually vehicle\/preservative-driven rather than peptide-specific),\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5722\" data-end=\"5824\"\u003e\n\u003cp data-start=\"5724\" data-end=\"5824\"\u003eheightened sensitivity when layered with strong actives (retinoids, acids) depending on formulation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"5826\" data-end=\"6042\"\u003eA 2025 review summarizes palmitoyl pentapeptide-4 as generally safe and non-sensitizing at commonly used levels in cosmetic contexts (as reported in the literature it cites). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"6044\" data-end=\"6047\"\u003e\n\u003ch2 data-start=\"6049\" data-end=\"6124\"\u003e8) Formulation and use considerations (what actually determines results)\u003c\/h2\u003e\n\u003cul data-start=\"6125\" data-end=\"6662\"\u003e\n\u003cli data-start=\"6125\" data-end=\"6349\"\u003e\n\u003cp data-start=\"6127\" data-end=\"6349\"\u003e\u003cstrong data-start=\"6127\" data-end=\"6145\"\u003eConcentration:\u003c\/strong\u003e Many references discuss ~\u003cstrong data-start=\"6171\" data-end=\"6199\"\u003e3% of the supplier blend\u003c\/strong\u003e as a common usage level; actual active peptide content in a “blend” can be much lower (supplier-dependent). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6350\" data-end=\"6456\"\u003e\n\u003cp data-start=\"6352\" data-end=\"6456\"\u003e\u003cstrong data-start=\"6352\" data-end=\"6372\"\u003eVehicle matters:\u003c\/strong\u003e penetration and stability are driven by emulsion type, solvents\/humectants, and pH.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6457\" data-end=\"6662\"\u003e\n\u003cp data-start=\"6459\" data-end=\"6662\"\u003e\u003cstrong data-start=\"6459\" data-end=\"6472\"\u003eTimeline:\u003c\/strong\u003e Expect changes over \u003cstrong data-start=\"6493\" data-end=\"6508\"\u003e8–12+ weeks\u003c\/strong\u003e for appearance metrics in most realistic regimens (consistent with typical topical anti-aging study durations). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"6664\" data-end=\"6667\"\u003e\n\u003ch2 data-start=\"6669\" data-end=\"6686\"\u003e9) Bottom line\u003c\/h2\u003e\n\u003cp data-start=\"6687\" data-end=\"7108\"\u003e\u003cstrong data-start=\"6687\" data-end=\"6726\"\u003eMatrixyl (palmitoyl pentapeptide-4)\u003c\/strong\u003e and \u003cstrong data-start=\"6731\" data-end=\"6800\"\u003eMatrixyl 3000 (palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7)\u003c\/strong\u003e are \u003cstrong data-start=\"6805\" data-end=\"6835\"\u003ecredible cosmetic peptides\u003c\/strong\u003e with a coherent mechanistic rationale (ECM signaling ± inflammation modulation) and a clinical record that supports \u003cstrong data-start=\"6952\" data-end=\"7022\"\u003emodest improvements in the appearance of wrinkles and skin texture\u003c\/strong\u003e when formulated well and used consistently. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"7110\" data-end=\"7384\"\u003eIf you tell me which product you mean—\u003cstrong data-start=\"7148\" data-end=\"7168\"\u003eMatrixyl (PPP-4)\u003c\/strong\u003e vs \u003cstrong data-start=\"7172\" data-end=\"7189\"\u003eMatrixyl 3000\u003c\/strong\u003e vs the newer \u003cstrong data-start=\"7203\" data-end=\"7224\"\u003eMatrixyl Synthe’6\u003c\/strong\u003e line—I can produce a \u003cstrong data-start=\"7246\" data-end=\"7268\"\u003ecomparative matrix\u003c\/strong\u003e (mechanism, best use-case, evidence strength, typical use level, and compatibility with retinoids\/acids\/vitamin C).\u003c\/p\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684838830418,"sku":null,"price":30.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/Matrixyl10mg.png?v=1770834792","url":"https:\/\/sciencepeptideslab.com\/products\/matrixyl-10mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}